At a glance
ClinicalIndex Comparison RecordN/ACompleted· 307 enrolled
Drug / intervention
Mupirocin and Chlorhexidine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Treating Parents to Reduce Neonatal Intensive Care Unit (NICU) Transmission of Staphylococcus Aureus
In Brief
A clinical study evaluating Mupirocin and Chlorhexidine and Placebo ointment and placebo cloths for Staph Aureus Colonization and Staph Aureus Infection. Completed, enrolled 307 participants across 2 sites.
Detailed Summary
This trial will test the hypothesis that treating parents of neonates requiring NICU care with intranasal mupirocin and topical chlorhexidine bathing will reduce the spread of S. aureus from parents to neonates.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsStaph Aureus Colonization, Staph Aureus Infection
CountriesUnited States
CollaboratorsAgency for Healthcare Research and Quality (AHRQ)
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedAug 2014
Enrollment StartNov 2014
Primary CompletionOct 2019
TodayJul 2026
First PostedAug 22, 2014
Enrollment StartNov 1, 2014
Primary CompletionOct 31, 2019
TodayJul 2, 2026
Enrollment to primary: 5 yearsPosted 11.9 years ago
Interventions
Mupirocin and Chlorhexidinedrug
Placebo ointment and placebo clothsdrug